| Literature DB >> 7561616 |
M L Villanueva-Peñacarrillo1, E Delgado, M A Trapote, A Alcántara, F Clemente, M A Luque, A Perea, I Valverde.
Abstract
We have found [125I]glucagon-like peptide (GLP)-1(7-36)amide specific binding activity in rat liver and isolated hepatocyte plasma membranes, with an M(r) of approximately 63,000, estimated by cross-linking and SDS-PAGE. The specific binding was time- and membrane protein concentration-dependent, and equally displaced by unlabelled GLP-1(7-36)amide and by GLP-1(1-36)amide, achieving its ID50 at 3 x 10(-9) M of the peptides. GLP-1(7-36)amide did not modify the basal or the glucagon (10(-8) M)-stimulated adenylate cyclase in the hepatocyte plasma membranes. These data, together with our previous findings of a potent glycogenic effect of GLP-1(7-36)amide in isolated rat hepatocytes, led us to postulate that the insulin-like effects of this peptide on glucose liver metabolism could be mediated by a type of receptor probably different from that described for GLP-1 in pancreatic B-cells or, alternatively, by the same receptor which, in this tissue as well as in muscle, uses a different transduction system.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7561616 DOI: 10.1677/joe.0.1460183
Source DB: PubMed Journal: J Endocrinol ISSN: 0022-0795 Impact factor: 4.286